
BPC157 10mg + GHK-CU 50mg + TB500 10mg + KPV 10mg KLOW80
KLW80 80 mg x 10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to QuoteSearch the full catalog and request batch-specific documentation, MOQ and lead time.

KLW80 80 mg x 10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
BBG70 70 mg x 10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
XT100 100iu10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
WA10 10 ml x 10 vials
Composition and microbiological criteria defined in the signed specificationPrice on Request
Add to Quote
VP10 10mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
TR20 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
TA5 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
TY10 10 mg
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
TY10 10mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
TSM2 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
BT10 10 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
TBF10 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
SUR10 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
STER10 10 ml
Composition and microbiological criteria defined in the signed specificationPrice on Request
Add to Quote
SS50 50 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
2S10 10 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
NP810 10 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
PP5 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
SMO5 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
XA5 5 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
SEMA20 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
SSXK 20 mg x 10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
SK5 5 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
RT20 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
PTD1 1 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
P41 10 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
P41 10 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
Pin 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
FMP2 2 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
PE22-28 5mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
PE10 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
P215 5 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
OT2 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
OS-01 100 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
NJ100 1000 mg
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
MS10 40 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
MS10 10 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
MK75 5mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
MIC 10 ml x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
FM2 2mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
MT2 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
MT1 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
ML10 10 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
MT-1 10 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
MZ10 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
MX10 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
KP5 5 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
375 5mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
LIRA30 30 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
LC216 10 ml
Composition and microbiological criteria defined in the signed specificationPrice on Request
Add to Quote
LB 10 ml
Composition and microbiological criteria defined in the signed specificationPrice on Request
Add to Quote
LC600 10 ml x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
LC1200 10 ml x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
LC1200 1200 mg
Composition and microbiological criteria defined in the signed specificationPrice on Request
Add to Quote
KPV5 5 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
KLOW80 80 mg
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
KS10 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
KS5 5 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
IP2 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
IGF-DES 2mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
IG01 0.1 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
IGF1 1 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
HUM10 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
G75 75iu10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
FRAG12 12 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
H10 10 iu x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
HGH15 15 iu
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
H10 10iu10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
HX2 5 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
HCG1000 1000 iu x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
GND2 5 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
GTT600 1500 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
GLOW70 70 mg
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
G65 5mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
G210 10mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
CU50 50 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
GDF-8 1 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
F402 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
FST-344 1mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
E3K 3000iu10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
ET10 40 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
332ELU-PP-332 5mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
DUL10 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
DS2 10 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
PNB-0408 10mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
DR5 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
CRY20 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
COR20 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
CND2 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
CD2 5 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
CP10 10 mg x 10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
CND2 2 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
CJCIPA510 10 mg
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
CP10 10 mg x 10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
CP20 20 mg x 10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
Cartalax 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
CAGSM5 5 mg
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
CS5 5mg10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
CGL5 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
CGL10 10 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
BRO20 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
BB10 10 mg x 10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
BB30 30 mg x 10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
BB20 20 mg x 10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
BC2 20 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
BB10 10 mg
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
BB30 30 mg
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
BC2 2mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
BB20 20 mg
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
BTX100 100 iu
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
BAC3 3 ml
Composition and microbiological criteria defined in the signed specificationPrice on Request
Add to Quote
BAC10 10 ml
Composition and microbiological criteria defined in the signed specificationPrice on Request
Add to Quote
BA10 10 ml x 10 vials
Composition and microbiological criteria defined in the signed specificationPrice on Request
Add to Quote
B72 2mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
B-12 20 ml x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
ARA16 16 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
RA10 10mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
2AD 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
AR100 100 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
AU50 50 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
ADIP10 10 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
AP2 2mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
AX 10mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
ACTH5 5 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
AAW10 10 ml
Composition and microbiological criteria defined in the signed specificationPrice on Request
Add to Quote
ACE0311 1 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
P21 10 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
50AM 50mg10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
5AM50 50 mg
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
5AM 5 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
10AM 10 mg x 10 vials
Target 98%+ by HPLC; final result reported on the batch COAPrice on Request
Add to Quote
B-12 10 ml
Composition and microbiological criteria defined in the signed specificationPrice on Request
Add to Quote
KLOW80 80 mg x 10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote
GLOW70(BB70) 70 mg x 10 vials
Component identity, ratio and total content confirmed against the signed blend specificationPrice on Request
Add to Quote